Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell disease.

A Yardumian1, C Crawley

  • 1Department of Haematology, North Middlesex Hospital, London.

Clinical Medicine (London, England)
|January 17, 2002
PubMed
Summary
This summary is machine-generated.

Sickle cell disease (SCD) is a significant health issue demanding continuous care for its medical and social effects. Emerging treatments show promise for altering the disease's progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups.

Bone marrow transplantation·2019
Same author

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.

Bone marrow transplantation·2017
Same author

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

Bone marrow transplantation·2017
Same author

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

Oncogene·2015
Same author

Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD.

Bone marrow transplantation·2014
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
Same journal

Heart failure with preserved ejection fraction (HFpEF): diagnosis and management for the general physician.

Clinical medicine (London, England)·2026
Same journal

Trends and Widening Inequities in Cardiovascular-Kidney-Metabolic Involvement in Cardiovascular Mortality: A National Spatiotemporal Analysis, 2014-2023.

Clinical medicine (London, England)·2026
Same journal

Educating current and future healthcare professionals on evidence-based sustainable medicine.

Clinical medicine (London, England)·2026
Same journal

UK Foundation Programme training needs a national minimum standard for advanced life support.

Clinical medicine (London, England)·2026
Same journal

Prognostic value of left atrial diameter in chronic kidney disease: The KNOW-CKD study.

Clinical medicine (London, England)·2026
See all related articles

Area of Science:

  • Hematology
  • Genetics
  • Public Health

Background:

  • Sickle cell disease (SCD) represents a major global health challenge.
  • It necessitates lifelong, multidisciplinary management due to extensive medical and social ramifications.

Purpose of the Study:

  • To review the current landscape of medical and social consequences associated with SCD.
  • To highlight novel therapeutic approaches with the potential to modify the natural history of SCD.

Main Methods:

  • Literature review of recent advancements in SCD management.
  • Analysis of emerging treatment strategies and their projected impact.

Main Results:

  • SCD presents a complex spectrum of health issues requiring comprehensive care.

Related Experiment Videos

  • Several new therapeutic avenues are being explored for SCD.

    • Conclusions:

    • Effective management of SCD involves addressing both clinical and psychosocial aspects.
    • Innovative treatments offer hope for improving the long-term outcomes of individuals with SCD.